✦ LIBER ✦

Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial

✍ Scribed by E. Del Fabbro, J. M. Garcia, R. Dev, D. Hui, J. Williams…

Book ID: 120913230
Publisher: Springer-Verlag
Year: 2013
Tongue: English
Weight: 293 KB
Volume: 21
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-013-1832-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Double-Blind Placebo Controlled Trial

A Double-Blind Placebo Controlled Trial of Testosterone Replacement for Fatigue in Males With Advanced Cancer (TH307-B)

✍ Del Fabbro, Egidio; Garcia, Jose; Dev, Rony; Palmer, Lynn 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Reduction of Cancer-Related Fatigue With

Reduction of Cancer-Related Fatigue With Dexamethasone: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Advanced Cancer

✍ Yennurajalingam, S.; Frisbee-Hume, S.; Palmer, J. L.; Delgado-Guay, M. O.; Bull, 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 221 KB

Effects of Testosterone Supplementation

Effects of Testosterone Supplementation on Depressive, Ageing Male, and Sexual Symptoms in Hypogonadal Men: a Randomized, Placebo-controlled, Double-blind Trial

✍ E. Giltay; Y. Tishova; L. Gooren; F. Saad; G. Mskhalaya; S. Kalinchenko 📂 Article 📅 2009 🏛 Dougmar Publishing Group, Inc. 🌐 English ⚖ 91 KB

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Impact of Dexamphetamine on Fatigue in Patients with Advanced Cancer

✍ Kirsten Anne Auret; Stephan A. Schug; Alexandra P. Bremner; Max Bulsara 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Dexamethasone for Symptom Distress in Ad

Dexamethasone for Symptom Distress in Advanced Cancer: A Double-Blind, Randomized, Placebo-Controlled Trial (TH307-C)

✍ Yennurajalingam, Sriram 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 41 KB

A double-blind, placebo-controlled, rand

A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results

✍ Jaime Coronel; Lucely Cetina; Irlanda Pacheco; Catalina Trejo-Becerril; Aurora G 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 210 KB